Home > Drug Search >
  • company_query: Birmex
  •   > 
Drug Filter
Category:
chemistry (11) biology (22)
Status:
Approved (2) Phase Ⅲ (6) Phase Ⅱ (15) Phase Ⅰ (10)
Clinical Stage:
Pending (5) Active (22) Discontinued (4)
Bio-Type:
Gene therapy (5) Cell therapy (1) Vaccine (14) Recombinant coagulation factor (1) Recombinant cytokines (1)
Indication:
Alzheimer's disease (AD) (1) Benign prostatic hypertrophy (1) Chronic neuropathic pain (1) Wiskott-Aldrich syndrome (1) Cytomegalovirus infections (1) HBV infection (2) HIV infection (1) Inflammatory bowel disease (1) Influenza virus infection (2) Insomnia (1) Melanoma (1) Neuropathic pain (1) Parkinson's disease (PD) (1) Pneumonia (1) Prostate cancer (1) Poliomyelitis (1) Psoriasis (1) Schizophrenia (1) Chronic granulomatous disease (1) Solid tumours (2) Leber congenital amaurosis (1) Type 2 diabetes (1) Head and neck cancer (1) Influenza A virus infections (1) Limb girdle muscular dystrophy (1) Colorectal cancer (2) Prostatitis (1) Type 1 diabetes (1) Hemophilia A (1) Rett's syndrome (1) Glioblastoma (2) Allergic asthma (1) Bacterial infection (1) Dental Caries (1)
Country:
Aprv. Year:
2015 (1) 2016 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top